SEC
Cuts Cases: SEC's Woodcock Goes Quality Over Quantity
SEC enforcement chief Woodcock commits to quality over quantity, signaling that borderline inquiries could quietly fall off the agency's docket.
Latest — Page 4
Deals
Pfeifer Exits AC Immune
Andrea Pfeifer ends her run at AC Immune, sending the company into its first-ever CEO search.
SEC
Judge Orders Musk, SEC to Explain $200M Deal
A federal judge wants answers on how Musk's SEC deal was reached, why it uses a trust, and whether White House meddling tainted the process.
FDA
Encoded Gene Therapy Cuts Dravet Seizures 76%
Encoded's gene therapy hit 76% seizure reduction in Dravet syndrome kids. Trial details are sparse and no regulatory path has been announced.
AI
Filed: 26 States Target AI Surveillance Pricing
Instacart's 23% grocery price gap experiment sparked a 26-state backlash: over 50 bills targeting AI surveillance pricing are now live.
Deals
equipifi Raises $34M to Build Bank BNPL
Left Lane Capital's $34M Series B in equipifi targets the 49% of credit union members already routing BNPL through outside providers.
SEC
Killed Citi's $24.5M CFPB Order 3 Years Early
CFPB killed Citi's Armenian discrimination order three years early. Vought told Congress the $24.5M fine was 17x the actual redress.
Legal
Disputes DOJ: Block Reserves $240M for Settlement
Block reserved $240M for a DOJ settlement it actively disputes, having already paid $295M to state and federal regulators for Cash App.
Legal
DOJ Indicts Dream Market's 'Speedstepper' on 12 Counts
The alleged 'Speedstepper' bought $1.7M in gold bars with Dream Market crypto proceeds. Now he faces 12 federal counts at up to 20 years each.
Deals
Bought for $500M, Intermex Faces NYC Regulatory Block
NYC Mayor Mamdani is asking regulators to kill Western Union's $500M Intermex buy, citing fee hikes that would hit immigrant families hardest.
Legal
Jho Low, Still Fugitive, Files 1MDB Pardon Bid
Jho Low, the 1MDB fugitive charged in the largest-ever FCPA case, petitioned DOJ for a pardon while his co-defendants serve prison time.
FDA
FDA Clears BeOne's Beqalzi as First BCL-2 for MCL
BeOne's Beqalzi won the first U.S. BCL-2 approval specifically for mantle cell lymphoma, with CLL giant Venclexta squarely in its sights.
Deals
FCC Clears AT&T, Starlink EchoStar Spectrum Deals
The FCC cleared EchoStar spectrum for AT&T and Starlink, leaving rural carriers to fight for secondary deals that may never materialize.
Legal
Foxconn Confirms Nitrogen Stole 8TB, 11M Files
Nitrogen ransomware claims 8TB and 11M documents stolen from Foxconn, with Apple, Nvidia, and Intel design files allegedly in the haul.
FDA
Ousted: Makary Exits FDA; Sanofi Pulls Tzield
Makary's ouster leaves FDA with three acting leaders as Sanofi pulls diabetes drug Tzield from his signature priority review program.
